Maximilian von EYNATTEN,Uli Christian BROEDL,Hans-Juergen WOERLE
申请号：
US15806389
公开号：
US20180125813A1
申请日:
2017.11.08
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to methods for treating or preventing chronic kidney disease and cardiovascular disease in patients with chronic kidney disease comprising administering empagliflozin to the patient.
